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A b s t r a c t
Background and aim: To develop a global cardiovascular disease (CVD) mortality risk model for the Polish population and 
to verify these data in the context of the SCORE risk algorithm.
Methods: We analysed data obtained in two multicentre national population studies, the WOBASZ study which was con-
ducted in 2003–2005 and included 14,769 subjects aged 20–74 years, and the WOBASZ Senior study which was conducted 
in 2007 and included 1096 subjects above 74 years of age. All these subjects were followed for survival status until 2012 and 
the cause of death was determined. The mean duration of follow-up was 8.2 years for WOBASZ study participants and about 
5 years for WOBASZ Senior study participants. Overall, 1436 subjects died, including 568 due to CVD. For the purpose 
of our analysis of overall and CVD mortality, 15 established risk factors were selected. Survival was analysed separately in 
WOBASZ and WOBASZ Senior study participants. Statistical methods included descriptive statistics, Kaplan-Meier curves, 
Cox proportional hazard models, and the SCORE risk algorithm. Measure of incompatibility of the SCORE risk model to the 
Polish population was determined as the difference between mortality rates by the SCORE risk quartiles and the Cox approach.
Results: During the 8-year follow-up of the WOBASZ study population, mortality due to CVD was 38% among men and 31% 
among women. The most common causes of CVD mortality were ischaemic heart disease (IHD, 33%) followed by cerebro-
vascular disease (17%) in men, and cerebrovascular disease (31%) followed by IHD (23%) in women. We found significant 
differences between men and women in regard to survival curves for both overall mortality and CVD mortality (p < 0.0001). 
For overall mortality among men and women, nearly all selected risk factors were shown to be significant in univariate analyses, 
except for high density lipoprotein cholesterol (HDL-C) level and the total cholesterol/HDL-C ratio in men, and smoking status 
in women. In multivariate analysis, independent predictors in men included age, glucose level, systolic blood pressure, and 
smoking status. In women, independent predictors were age, smoking status, and diabetes. During the 5-year follow-up of the 
WOBASZ Senior study population, mortality due to CVD was 48% among men and 58% among women. The most common 
cause of CVD mortality in both men and women was IHD (29% and 24%, respectively), followed by cerebrovascular disease 
(16% and 21%, respectively). We found significant differences between men and women in regard to survival curves for overall 
mortality (p < 0.0001) but not for CVD mortality (p = 0.0755). Due to the fact that survival curves for CVD mortality did not 
differ between men and women, we estimated the cut-off age for no survival difference in the WOBASZ study. By selecting 
the oldest patients and adding them to the WOBASZ Senior cohort, we obtained the cut-off age of 70 years above which 
the survival curves were not significantly different between men and women. In univariate analyses, independent predictors 
in men were age and creatinine level. These factors remained significant in multivariate analysis. In women above 74 years 
of age, independent predictors in univariate analyses included age, HDL-C level, creatinine level, total cholesterol/HDL-C 
ratio, and smoking status. Age, HDL-C level, creatinine level, and smoking status remained independent predictors of overall 
mortality in multivariate analysis. For CVD mortality, significant predictors were the same as for overall mortality. In women, 
significant predictors in uni- and multivariate analyses were age and smoking status. Overall disagreement between CVD 
mortality rates by the SCORE risk model and the Cox model was 5.7% in men and 2% in women.
Address for correspondence:  
Walerian Piotrowski, MD, PhD, Institute of Cardiology, ul. Alpejska 42, 04–628 Warszawa, Poland, e-mail: wpiotrowski@ikard.pl 
Received: 18.02.2015 Accepted: 20.08.2015 Available as AoP: 09.09.2015
Kardiologia Polska Copyright © Polskie Towarzystwo Kardiologiczne 2016
www.kardiologiapolska.pl
Global cardiovascular mortality risk in the adult Polish population
263
INTRODUCTION
Cardiovascular disease (CVD) is a major cause of morbid-
ity, disability, and premature mortality. A reduction in CVD 
mortality has been observed in Poland since early 1990s, 
amounting to 30% in 1997–2001. However, mortality rates 
remain worse compared to other European Community 
countries, e.g. they continued to be nearly 2-fold higher in 
2011. Notably, these adverse mortality rates are mostly seen 
among young and middle-age subjects, with mortality in this 
age group being 2.5-fold higher compared to other European 
Community countries. Large regional differences are also 
observed in Poland, estimated at about 25–30% among those 
aged 20–74 years. Reasons for this variation are complex. They 
may depend on socioeconomic conditions, lifestyle, and the 
regional healthcare level [1, 2].
The idea of a risk factor for a given event has originated 
from the Framingham and Seven Countries studies [3]. Ac-
cording to the definition by Simborg [4], risk factor is a feature 
or symptom occurring in the population which is statistically 
associated with an increased disease incidence or mortality. 
Risk factors define subjects at a risk of future pathology despite 
its absence at the time of evaluation. The value of a specific 
risk factor is an individual feature that affects the likelihood 
of occurrence of the event being studied. A world literature 
review by Hopkins and Williams [5] identified at least 246 fac-
tors that showed a significant correlation with ischaemic heart 
disease (IHD) incidence in at least one study.
Long-term epidemiological studies showed that concomi-
tant presence of several risk factors resulted in a synergistically 
and not additively increased risk. Then, the global risk may be 
much more increased with even modest elevation of several 
risk factors compared to that associated with highly elevated 
but single risk factors. 
Conclusion from these studies prompted a research inter-
est in multivariate statistical analyses. Based on such analyses 
performed in the United States in the early 1960s, American 
Heart Association first published tables [6] that allowed esti-
mation of the likelihood of IHD incidence in relation to such 
factors as gender, age, cigarette smoking, blood pressure (BP), 
serum cholesterol level, glucose, tolerance, and electrocardio-
graphic evidence of left ventricular hypertrophy, followed by 
development, with a support from Merck Sharp & Dohme, 
of a risk calculator known as Coronary Risk Assessor.
This risk calculator also allowed comparing an individual 
risk with a hypothetical individual of the same gender and 
age but free from the risk factors, thus increasing patients’ 
motivation for lifestyle changes.
In Europe, the European Systematic COronary Risk Evalu-
ation (SCORE) algorithm is used since 2003 to estimate the 
10-year CVD mortality risk in relation to risk factors including 
gender, age, total cholesterol level, systolic BP, and cigarette 
smoking [7]. The global SCORE risk has been used to develop 
guidelines and recommendations to increase public awareness 
of the need for lifestyle changes, e.g. smoking cessation and 
dietary modification. Based on the SCORE risk algorithm, the 
European Society of Cardiology  guidelines for the prevention 
of CVD have been developed and endorsed by the Polish 
Cardiac Society and the Polish Society of Hypertension [8–11].
Since that time, the concept of global risk has been 
frequently used to develop preventive recommendations for 
multiple types of CVD.
It is known, however, that the use of an algorithm devel-
oped to estimate the risk in a given population may lead to risk 
overestimation or underestimation in other populations [12]. 
Thus, the SCORE risk algorithm that is currently used in guide-
lines targeted at the Polish population needs to be validated.
Based on the results of multicentre national study to evalu-
ate the health status of the Polish population (Wieloośrodkowe 
Ogólnopolskie Badanie Stanu Zdrowia Ludności [WOBASZ]), 
the SCORE risk algorithm has been validated for the Polish 
population aged 35–64 years.
The aim of the present study was to develop a global 
CVD mortality risk model for the Polish population and to 
verify these data in the context of the SCORE risk algorithm.
METHODS
Patients
We analysed data obtained in two research projects, the 
WOBASZ study which was conducted in 2003–2005 and 
included 14,769 subjects aged 20–74 years, and the WOBASZ 
Senior study which was conducted in 2007 and included 
1096 subjects above 74 years of age. Study goals, patient sam-
ples, and methods used in these two projects were reported 
previously [13]. In both studies, methods were similar and 
included evaluation of the prevalence and levels of selected 
CVD risk factors.
Conclusions: 1. Long-term follow-up of WOBASZ and WOBASZ Senior study participants allowed assessment of the inde-
pendent association of the evaluated cardiovascular risk factors with CVD mortality in the Polish population. 2. Validation of 
the SCORE risk algorithm to estimate individual global CVD risk in the Polish population showed a high predictive value of 
this algorithm.
Key words: WOBASZ, WOBASZ Senior, cardiovascular disease, global risk, SCORE
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For the purpose of the present analysis, we selected 
15 variables which are established CVD mortality risk factors.
To accomplish study goals, we conducted a prospec-
tive follow-up of participants of both studies. The follow-up 
of the WOBASZ study participants included two stages in 
2007–2009 (the Polish Ministry of Health projects under the 
POLKARD programme) and 2012–2014 (a grant from the 
National Science Centre). In 2003–2008 (5-year follow-up), 
a total of 507 deaths were identified (including 352 among 
men and 155 among women), and when the follow-up was 
extended to 2012 (8-year follow-up), overall 1085 deaths 
were identified, including 385 deaths due to CVD (274 among 
men and 111 among women).
Previously, the WOBASZ Senior study participants have 
not been subjected to a prospective follow-up and the sur-
vival status in this cohort was established for the first time. 
In 2007–2012, 351 subjects died, including 101 men and 
82 women due to CVD.
Determination of survival status  
and the cause of death
To determine survival status of the WOBASZ and WOBASZ 
Senior study participants, we used the Polish national personal 
identification number database (Universal Electronic System 
for Registration of the Population, Powszechny Elektroniczny 
System Ewidencji Ludności [PESEL]) run by the Ministry of the 
Interior. After obtaining information on patients’ deaths with 
their dates, we used yearly mortality databases run by the 
Central Statistical Office (Główny Urząd Statystyczny [GUS]). 
Based on 4 identifying features including the address, gen-
der, date of birth, and date of death, the cause of death was 
retrieved from the GUS database. If the cause of death could 
not be precisely ascertained (due to several records with the 
same 4 identifying features), death was classified as due to 
non-cardiac reasons.
Table 1 shows the mean duration of follow-up in the 
WOBASZ and WOBASZ Senior studies.
Statistical analysis
Statistical analysis included descriptive statistics for the basic 
sample estimators, levels of selected mortality risk factors, and 
determination of predictors of all-cause and CVD mortality. 
Hypotheses were verified using parametric (Student t test) and 
non-parametric (Wilcoxon test and c2 test) tests, depending 
on the distribution of the analysed variables.
In statistical analyses of CVD mortality, deaths due to 
non-CVD causes were treated as censored observations.
Survival was evaluated using Kaplan-Meier curves. Sur-
vival curves were compared using the log-rank test. Predictive 
value of selected risk factors was determine using uni- and 
multivariate Cox proportional hazard regression models [14]. 
Variables showing significance in a multivariate model were 
selected using the stepwise approach. Personal index (PI) 
values obtained for each patient in multivariate Cox model 
were correlated with SCORE risk values determined using the 
algorithm reported previously [7]. 
Evaluation of the concordance of global  
SCORE risk estimates in the Polish population
Based on published 10-year CVD mortality risk estimates using 
the SCORE risk algorithm [7, 12], an individual 10-year risk 
value was determined for each WOBASZ study participant 
aged 35–64 years. The SCORE risk algorithm was validated in 
the Polish population by comparing mortality rates in SCORE 
risk quartiles and mortality risk quartiles by the Cox approach. 
The sum of absolute differences between these mortality rates 
in all quartiles is the measure of disagreement [15].
All statistical analyses were performed separately for men 
and women.
Statistical conclusions were based on two-tailed test with 
the significance level set at alpha = 0.05. Statistical calcula-
tions were performed using the SAS package, version 9.2.
RESULTS
Baseline characteristics of the WOBASZ and WOBASZ Senior 
study participants were reported previously [16].
Tables 2 and 3 show basic parameters of the analysed 
risk factors for all-cause and CVD mortality.
Statistically significant differences in most established 
CVD risk factors were found between the genders in the Polish 
population aged 20–74 years. The mean levels of these risk 
factors were mostly higher in men, with the exception of 
abdominal obesity which was more common among women. 
Also the mean high density lipoprotein cholesterol (HDL-C) 
level was adversely lower in men compared to women.
Among the WOBASZ Senior study participants (above 
74 years of age), major differences in the mean levels and 
rates of the analysed risk factors were also observed between 
the two genders but adversely higher mean values were noted 
in women.
Table 1. Mean (± standard deviation [SD]) duration of the follow-up
Gender WOBASZ WOBASZ Senior
N Mean ± SD N Mean ± SD
Men 6977 8.12 ± 1.54 555 4.69 ± 1.76
Women 7792 8.36 ± 1.05 541 5.06 ± 1.5
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Tables 4 and 5 show the number of deaths overall and 
due to CVD during the 8-year follow-up of the WOBASZ 
study participants and 5-year follow-up of the WOBASZ 
Senior study participants.
During the 8-year follow-up of the younger population, 
mortality due to CVD was 38% among men and 31% among 
women. The most common causes of CVD mortality were 
IHD (33%) followed by cerebrovascular disease (17%) in 
Table 2. Description of the study material (mean ± standard deviation [SD], median, and interquartile range) — WOBASZ study
Risk factor Men Women P
Mean ± SD Median (25%; 75%) Mean ± SD Median (25%; 75%)
Age [years] 45.6 ± 15.2 46 (33;57) 45.2 ± 15.1 46 (32; 56) 0.0852a
Body mass index [kg/m2] 26.6 ± 4.5 26.2 (23.5; 29.2) 26.1 ± 5.6 25.1 (21.9; 29.4) < 0.0001a
Glucose [mmol/L] 5.12 ± 1.47 4.8 (4.4; 5.4) 4.88 ± 1.34 4.7 (4.3; 5.1) < 0.0001a
Cholesterol [mmol/L] 5.38 ± 1.15 5.31 (4.57; 6.07) 5.37 ± 1.19 5.27 (4.54; 6.08) 0.2422a
HDL-C [mmol/L] 1.36 ± 0.41 1.30 (1.08; 1.55) 1.54 ± 0.38 1.51 (1.28; 1.77) < 0.0001a
LDL-C [mmol/L] 3.35 ± 1.05 3.25 (2.62; 4.02) 3.31 ± 1.06 3.23 (2.54; 3.92) 0.1208a
Triglycerides [mmol/L] 1.68 ± 1.50 1.31 (0.93; 1.93) 1.32 ± 0.95 1.10 (0.81; 1.57) < 0.0001a
Total cholesterol/HDL-C ratio 3.36 ± 1.54 3.1 (2.2; 4.2) 2.72 ± 1.35 2.4 (1.8; 3.4) < 0.0001a
Diastolic BP [mm Hg] 83.7 ± 11.8 82.5 (75.5; 90) 81.4 ± 11.8 80 (73; 88) < 0.0001a
Systolic BP [mm Hg] 137.3 ± 18.9 134.5 (125; 146) 129.9 ± 21.8 125 (115; 139) < 0.0001a
Smokers [%] 42.2 27.2 < 0.0001c
Abdominal obesity [%]1 24.9 38.4 < 0.0001c
Diabetes [%]2 7.2 6.1 0.0049c
Hypertension [%]3 40.1 32.1 < 0.0001c
aWilcoxon test; cChi-square test; 1Waist circumference: men ≥ 102 cm, women ≥ 88 cm; 2Glucose level ≥ 7.0 mmol/L and/or use of glucose-
-lowering drugs; 3Systolic BP ≥ 140 mm Hg and/or diastolic BP ≥ 90 mm Hg and/or use of antihypertensive drugs; BP — blood pressure;  
HDL-C — high density lipoprotein cholesterol; LDL-C — low density lipoprotein cholesterol
Table 3. Description of the study material (mean ± standard deviation [SD], median, and interquartile range) — WOBASZ Senior 
study
Risk factor Men Women P
Mean ± SD Median (25%; 75%) Mean ± SD Median (25%; 75%)
Age [years] 79.0 ± 3.9 78 (76; 81) 79.2 ± 3.4 79 (77; 81) 0.0269a
Body mass index [kg/m2] 27.1 ± 4.2 26.6 (24.3; 29.10) 28.8 ± 5.9 28.0 (24.6; 32.4) < 0.0001a
Glucose [mmol/L] 5.56 ± 2.08 5.0 (4.6; 5.7) 5.71 ± 2.11 5.10 (4.7; 5.8) 0.2695a
Cholesterol [mmol/L] 4.95 ± 1.02 4.89 (4.31; 5.60) 5.40 ± 1.13 5.44 (4.64; 6.20) < 0.0001b
HDL-C [mmol/L] 1.31 ± 0.37 1.27 (1.06; 1.51) 1.39 ± 0.38 1.34 (1.10; 1.63) 0.0006a
Creatinine [µmol/L] 88.4 ± 27.9 82 (72; 96) 75.4 ± 40.6 68 (59; 83) < 0.0001a
LDL-C [mmol/L] 3.23 ± 0.96 3.23 (2.60; 3.76) 3.50 ± 1.06 3.47 (2.79; 4.22) < 0.0001b
Triglycerides [mmol/L] 1.17 ± 0.59 1.04 (0.78; 1.37) 1.48 ± 0.74 1.31 (1.00; 1.72) < 0.0001a
Total cholesterol/HDL-C ratio 3.02 ± 1.33 2.78 (2.16; 3.63) 3.12 ± 1.31 2.87 (2.28; 3.66) 0.2317a
Diastolic BP [mm Hg] 83.7 ± 11.4 83.0 (75.5; 90.5) 86.7 ± 12.9 87.0 (79; 94.5) < 0.0001b
Systolic BP [mm Hg] 151.2 ± 23.2 147.5 (133.5; 166.5) 155.0 ± 24.5 153 (137; 170) 0.0086a
Smokers [%] 14.2 3.3 < 0.0001c
Abdominal obesity [%]1 38.1 72.3 < 0.0001c
Diabetes [%]2 16.9 18.8 0.4077c
Hypertension [%]3 74.9 86.6 < 0.0001c
aWilcoxon test; bStudent t test; cChi-square test; 1Waist circumference: men ≥ 102 cm, women ≥ 88 cm; 2Glucose level ≥ 7.0 mmol/L and/or use of 
glucose-lowering drugs; 3Systolic BP ≥ 140 mm Hg and/or diastolic BP ≥ 90 mm Hg and/or use of antihypertensive drugs; BP — blood pressure; 
HDL-C — high density lipoprotein cholesterol; LDL-C — low density lipoprotein cholesterol
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men, and cerebrovascular disease (31%) followed by IHD 
(23%) in women.
During the 5-year follow-up of the older population, 
mortality due to CVD was 48% among men and 58% among 
women. The most common cause of CVD mortality in both 
men and women was IHD (29% and 24%, respectively), 
followed by cerebrovascular disease (16% and 21%, respec-
tively).
Figure 1 shows survival curves for overall mortality during 
8 years of follow-up, and survival curves for CVD mortality.
Table 4. Number of deaths among WOBASZ study participants
Years of follow-up Men Women
Deaths overall Deaths due to CVD Deaths overall Deaths due to CVD
Within one year 68 33 20 7
I year 80 28 37 15
II year 82 36 36 12
III year 77 26 33 9
IV year 87 21 48 13
V year 86 28 47 11
VI year 84 36 61 20
VII year 96 42 50 13
VIII year 67 24 26 11
Overall 727 274 358 111
CVD — cardiovascular disease
Table 5. Number of deaths among WOBASZ Senior study participants
Years of follow-up Men Women
Deaths overall Deaths due to CVD Deaths overall Deaths due to CVD
Within one year 42 23 22 11
I year 33 18 24 13
II year 41 17 23 12
III year 29 11 33 18
IV year 33 18 21 15
V year 31 14 19 13
Overall 209 101 142 82
CVD — cardiovascular disease
Figure 1. Kaplan-Meier 8-year survival curves for the Polish population aged 20–74 years estimated for WOBASZ study partici-
pants; A. Total mortality; B. Cardiovascular disease mortality
A B
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We found significant differences between men and 
women in regard to survival curves for both overall mortality 
and CVD mortality (p < 0.0001).
Predictive value of the analysed risk factors for overall 
mortality in uni- and multivariate models is shown in Table 6.
For overall mortality among men and women, nearly all 
selected risk factors were shown to be significant in univari-
ate analyses, except for HDL-C level and the total choles-
terol/HDL-C ratio in men, and smoking status in women.
In multivariate analysis, independent predictors in men 
included age, glucose level, systolic BP, and smoking status. In 
women, independent predictors were age, smoking status, 
and diabetes.
Predictive value of the analysed risk factors for CVD 
mortality is shown in Table 7.
For CVD mortality among men and women, nearly all 
selected risk factors were shown to be significant in univari-
ate analyses, except for HDL-C, triglycerides, and the total 
cholesterol/HDL-C ratio in men, and triglycerides and smoking 
status in women.
In multivariate analysis, independent predictors in men 
included age, glucose level, smoking status, and hyperten-
sion. In women, independent predictors were age, systolic 
BP, and diabetes.
Survival curves in the WOBASZ Senior study are shown 
in Figure 2.
We found significant differences between men and 
women in regard to survival curves for overall mortality 
(p < 0.0001) but not for CVD mortality (p = 0.0755).
Due to the fact that survival curves for CVD mortality 
did not differ between men and women, we estimated the 
cut-off age for no survival difference in the WOBASZ study. By 
selecting the oldest patients and adding them to the WOBASZ 
Senior cohort, we obtained the cut-off age of 70 years above 
which the survival curves were not significantly different be-
tween men and women (Fig. 3).
Predictive value of the analysed risk factors for overall 
mortality in uni- and multivariate models for the WOBASZ 
Senior study participants is shown in Table 8.
In univariate analyses, independent predictors in men 
were age and creatinine level. These factors remained sig-
nificant in multivariate analysis. In women above 74 years of 
age, independent predictors in univariate analyses included 
age, HDL-C level, creatinine level, total cholesterol/HDL-C 
ratio, and smoking status. Age, HDL-C level, and smoking 
status remained independent predictors of overall mortality 
in multivariate analysis.
Predictive value of the analysed risk factors for CVD 
mortality is shown in Table 9.
For CVD mortality, significant predictors were the same 
as for overall mortality. In women, significant predictors in 
uni- and multivariate analyses were age and smoking status.
In the next step, we estimated the goodness of fit 
of the SCORE risk model to the Polish population aged 
35–64 years. Table 10 shows the findings of the multivariate 
Cox analysis of the factors included in the SCORE risk model. 
In the Polish population, we found no statistical significance 
of total cholesterol level in the Cox model that included the 
Table 6. Uni- and multivariate Cox analysis findings in the WOBASZ study — relative risk (95% confidence interval) for overall 
mortality
Risk factor Men Women
Univariate model Multivariate model Univariate model Multivariate model
Age 1.086 (1.079–1.093) 1.092 (1.084–1.100) 1.097 (1.087–1.108) 1.103 (1.091–1.115)
Body mass index 1.032 (1.017–1.048) – 1.068 (1.051–1.085) –
Glucose 1.167 (1.136–1.200) 1.079 (1.038–1.121) 1.212 (1.174–1.252) –
Total cholesterol 1.190 (1.121–1.263) – 1.239 (1.150–1.336) –
HDL-C 1.137 (0.956–1.352) – 0.699 (0.523–0.934) –
LDL-C 1.005 (1.003–1.007) – 1.006 (1.004–1.008) –
Triglycerides 1.000 (1.000–1.001) – 1.001 (1.001–1.002) –
Total cholesterol/HDL-C ratio 1.076 (0.982–1.179) – 1.180 (1.080–1.289) –
Diastolic BP 1.024 (1.018–1.030) – 1.034 (1.027–1.042) –
Systolic BP 1.021 (1.018–1.024) 1.008 (1.001–1.014) 1.025 (1.021–1.029) –
Smoking status 1.114 (1.062–1.290) 1.791 (1.531–2.096) 0.958 (0.757–1.213) 2.278 (1.742–2.980)
Abdominal obesity 1.980 (1.705–2.300) – 2.415 (1.952–2.986) –
Diabetes 2.608 (2.138–3.181) – 4.782 (3.729–6.132) 2.018 (1.547–2.632)
Hypertension 2.362 (2.036–2.740) – 4.045 (3.253–5.029) –
BP — blood pressure; HDL-C — high density lipoprotein cholesterol; LDL-C — low density lipoprotein cholesterol
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four variables included in the SCORE risk model. In women, 
smoking status was also not significant.
Tables 11 and 12 show CVD mortality rates in the SCORE 
risk model and the Cox model quartiles along with discrepan-
cies between these rates.
DISCUSSION
Confirmation of the fact that modifiable risk factors (elevated 
cholesterol, body mass index, and BP, cigarette smoking, 
and others) affect CVD morbidity and mortality justifies pre-
ventive efforts. The degree of an event risk is measured by 
individual patient status that encompasses a range of personal 
characteristics. These characteristics, analysed using statistical 
methods and used to model the studied phenomenon, allow 
Table 7. Uni- and multivariate Cox analysis findings in the WOBASZ study — relative risk (95% confidence interval) for cardio-
vascular mortality
Risk factor Men Women
Univariate model Multivariate model Univariate model Multivariate model
Age 1.094 (1.083–1.106) 1.090 (1.077–1.104) 1.129 (1.106–1.152) 1.107 (1.082–1.133)
Body mass index 1.043 (1.018–1.069) – 1.075 (1.045–1.105) –
Glucose 1.172 (1.121–1.225) 1.081 (1.014–1.151) 1.248 (1.187–1.312) –
Total cholesterol 1.270 (1.156–1.396) – 1.256 (1.100–1.435) –
HDL-C 1.124 (0.845–1.494) 0.442 (0.256–0.765) –
LDL-C 1.007 (1.004–1.010) – 1.007 (1.003–1.011) –
Triglycerides 1.000 (0.999–1.001) – 1.002 (0.998–1.002) –
Total cholesterol/HDL-C ratio 0.975 (0.834–1.140) – 1.234 (1.096–1.390) –
Diastolic BP 1.029 (1.019–1.038) – 1.044 (1.031–1.058) –
Systolic BP 1.024 (1.019–1.029) – 1.033 (1.027–1.039) 1.011 (1.003–1.020)
Smoking status 1.477 (1.244–1.768) 1.647 (1.270–2.137) 0.516 (0.312–1.855) –
Abdominal obesity 2.217 (1.741–2.824) – 3.244 (2.184–4.818) –
Diabetes 2.916 (2.136–3.982) – 7.017 (4.671–10.543) 2.538 (1.636–3.938)
Hypertension 3.200 (2.487–4.119) 1.598 (1.215–2.100) 5.533 (3.649–8.389) –
BP — blood pressure; HDL-C — high density lipoprotein cholesterol; LDL-C — low density lipoprotein cholesterol
Figure 2. Kaplan-Meier 5-year survival curves for the Polish population aged 75 years and above estimated based on data from 
the WOBASZ Senior study; A. Total mortality; B. Cardiovascular disease mortality
Figure 3. Kaplan-Meier survival curves for men and women 
aged 70 years and above
A B
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determination of the overall risk which is a measure of the 
likelihood of disease occurrence, presence, or severity, or the 
occurrence of death. Determination of the overall patient 
risk, also known as global risk, should be a responsibility 
of a physician. In the Framingham study, the algorithm to 
estimate the likelihood of CVD symptom occurrence within 
a specified period of time (from 4 to 12 years) was based on 
systolic BP, total cholesterol and HDL-C level, electrocardio-
graphic evidence of left ventricular hypertrophy, age, and the 
presence of diabetes [17].
Table 8. Uni- and multivariate Cox analysis findings in the WOBASZ Senior study — relative risk (95% confidence interval) for 
overall mortality
Risk factor Men Women
Univariate model Multivariate model Univariate model Multivariate model
Age 1.099 (1.069–1.131) 1.096 (1.063–1.130) 1.131 (1.086–1.177) 1.128 (1.072–1.187)
Body mass index 1.002 (0.968–1.036) – 0.997 (0.968–1.027) –
Glucose 1.016 (0.950–1.087) – 1.034 (0.958–1.116) –
Total cholesterol 1.080 (0.934–1.239) – 0.885 (0.752–1.041) –
HDL-C 1.015 (0.672–1.534) – 0.435 (0.258–0.731) 0.579 (0.337–0.993)
Creatinine 1.012 (1.007–1.016) 1.011 (1.006–1.016) 1.007 (1.004–1.010) 1.007 (1.004–1.010)
LDL-C 1.048 (0.897–1.225) – 0.872 (0.732–1.038) –
Triglycerides 1.001 (0.998–1.003) – 0.999 (0.997–1.005) –
Total cholesterol/HDL-C ratio 1.081 (0.965–1.210) – 1.155 (1.013–1.317) –
Diastolic BP 0.991 (0.979–1.003) – 0.994 (0.981–1.008) –
Systolic BP 1.001 (0.995–1.007) – 1.000 (0.993–1.007) –
Smoking status 1.167 (0.805–1.693) – 2.094 (1.026–4.275) 3.582 (1.640–7.826)
Abdominal obesity 1.200 (0.911–1.581) – 1.014 (0.695–1.479) –
Diabetes 1.301 (0.930–1.819) – 1.022 (0.672–1.555) –
Hypertension 1.044 (0.760–1.435) – 1.074 (0.655–1.761) –
BP — blood pressure; HDL-C — high density lipoprotein cholesterol; LDL-C — low density lipoprotein cholesterol
Table 9. Uni- and multivariate Cox analysis findings in the WOBASZ Senior study — relative risk (95% confidence interval) for 
cardiovascular mortality
Risk factor Men Women
Univariate model Multivariate model Univariate model Multivariate model
Age 1.146 (1.106–1.187) 1.143 (1.101–1.187) 1.116 (1.056–1.179) 1.120 (1.046–1.199)
Body mass index 1.018 (0.970–1.068) – 1.000 (0.962–1.040) –
Glucose 1.052 (0.976–1.133) – 1.038 (0.940–1.147) –
Total cholesterol 1.089 (0.889–1.334) – 0.945 (0.765–1.169) –
HDL-C 0.795 (0.436–1.449) – 0.555 (0.287–1.072) –
Creatinine 1.013 (1.007–1.019) 1.010 (1.004–1.017) 1.004 (0.997–1.010) –
LDL-C 1.073 (0.863–1.333) – 0.915 (0.728–1.148) –
Triglycerides 1.002 (0.999–1.006) – 0.999 (0.996–1.006) –
Total cholesterol/HDL-C ratio 1.148 (0.989–1.333) – 1.115  (0.935–1.329) –
Diastolic BP 0.981 (0.963–1.000) – 0.998 (0.980–1.016) –
Systolic BP 1.001 (0.993–1.010) – 1.001 (0.992–1.010) –
Smoking status 0.760 (0.406–1.421) – 1.809 (1.662–4.943) 3.291 (1.182–9.159)
Abdominal obesity 1.363 (0.919–2.021) – 1.094 (0.658–1.819) –
Diabetes 1.565 (0.990–2.475) – 1.053 (0.610–1.818) –
Hypertension 1.179 (0.735–1.892) – 1.114 (0.575–2.160) –
BP — blood pressure; HDL-C — high density lipoprotein cholesterol; LDL-C — low density lipoprotein cholesterol
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In the PROCAM study, the algorithm to determine 8-year 
probability of myocardial infarction or sudden death due to 
CVD was based on such risk factors as age, systolic BP, HDL-C 
and low density lipoprotein cholesterol level, triglycerides, 
smoking, the presence of diabetes and angina pectoris, and 
a positive family history of myocardial infarction [17].
The 10-year CVD mortality risk estimated using the 
SCORE risk algorithm is based on four risk factors including 
age, total cholesterol, systolic BP, and smoking status, with 
separate estimations for men and women. Patients with 
diabetes or glucose level ≥ 7 mmol/L, and those with a his-
tory of myocardial infarction or coronary artery disease are 
considered high risk.
In contrast to the above algorithms, the global CVD 
mortality risk model for the Polish population aged 
20–74 years did not include lipid levels including HDL-C, 
total cholesterol, and triglycerides. The WOBASZ study 
population was characterised by high HDL-C levels (mean 
levels 1.36 mmol/L and 1.54 mmol/L, respectively, in men 
and women) with distribution close to a uniform one (low 
standard deviation values). For this reason, HDL-C level did 
not reach significance in the multivariate model. A similar 
scenario was noted for total cholesterol level, with the 
coefficient of variation up to 21%. A strong correlation be-
tween triglyceride levels and age is observed in the Polish 
population. When age was introduced into the model as 
the strongest non-modifiable risk factors, triglyceride level 
was excluded.
Our observations confirm a significant association be-
tween systolic BP and CVD mortality, similarly to the men-
tioned global risk models.
Prospective studies confirmed clinical observations of 
an increased CVD incidence associated with the presence of 
diabetes. In the Framingham study, diabetes was associated 
with a 2-fold increase in CVD mortality [17].
The SCORE risk algorithm to estimate a 10-year risk of 
a cardiac event in men and women aged 35–64 years has been 
based on multinational, multicentre prospective studies. To 
develop a model of a 10-year CVD mortality risk, data from 
12 European cohort studies were used, performed in Finland, 
Russia, Norway, United Kingdom (two cohorts), Denmark, 
Sweden, Belgium, Germany, Italy, France, and Spain. The 
analysis included 88,080 women and 117,098 men aged 
45–64 years. During the follow-up, 7934 CVD deaths oc-
curred, including 5652 deaths due to IHD. The cohorts were 
divided into two groups corresponding to low- and high-risk 
countries, with a SCORE risk algorithm developed separately 
for each of these groups [7]. Data from the Polish population 
were not included, and thus SCORE risk model parameters do 
not take into account the characteristics of the Polish popula-
tion. The algorithm used in the WOBASZ study was based on 
the SCORE risk algorithm for high-risk countries.
Table 10. Relative risk and 95% confidence interval values for global SCORE risk components in the Polish population aged 
35–64 years
Risk factor Men Women
Age 1.082 (1.056–1.109) 1.062 (1.010–1.118)
Cholesterol 1.146 (0.988–1.328) 0.991 (0.750–1.310)
Systolic blood pressure 1.012 (1.004–1.020) 1.024 (1.010–1.037)
Smoking status 1.675 (1.192–2.353) 1.087 (0.515–2.294)
Table 11. Cardiovascular mortality rates in risk quartiles by SCORE and Cox model in men aged 35–64 years in the WOBASZ 
study; ∑ difference = 5.7% 
Algorithm 1st quartile 2nd quartile 3rd quartile 4th quartile
SCORE 1.4% 1.3% 4.0% 13.9%
Cox 0% 1.6% 2.8% 11.1%
Difference 1.4% 0.3% 1.2% 2.8%
Table 12. Cardiovascular mortality rates in risk quartiles by SCORE and Cox model in women aged 35–64 years in the WOBASZ 
study; ∑ difference = 2.0% 
Algorithm 1st quartile 2nd quartile 3rd quartile 4th quartile
SCORE 0.3% 0.5% 1.0% 5.4%
Cox 0% 0.4% 0.6% 4.2%
Difference 0.3% 0.1% 0.4% 1.2%
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Use of a multivariate Cox proportional hazard model 
based on risk factors included in the SCORE risk algorithm 
showed that in the Polish population, only three of them in 
men (age, smoking, and elevated systolic BP) and two in 
women (age and elevated systolic BP) were predictors of fatal 
CVD events. In contrast, elevated total cholesterol level was 
not a significant risk factor in this population. The latter obser-
vation is apparently at variance with the widely accepted no-
tion of a significant association between total cholesterol level 
and CVD mortality. In the recent study by Bandosz et al. [18], 
a reduction in cholesterol level was shown to be responsible 
for 39% of the IHD mortality reduction observed in Poland in 
1991–2005. To explain these discrepant conclusions, it should 
be noted that in analyses from the WOBASZ study, choles-
terol level was a significant predictor of CVD mortality but 
only in an univariate analysis. A positive association between 
age and cholesterol level is known. In multivariate analyses 
that include both these variables, only one of them, i.e. age, 
remained significant due to the strength of this correlation. 
Data used for the analyses reported in the IMPACT study [18] 
characterised the general Polish population aged 20–74 years 
in terms of the mean values of continuous variables, such as 
cholesterol level, and event rates, such as smoking, hyperten-
sion, and others (not individual patient-level data). At each 
time point in 1991–2005, the age range in the study popu-
lation was the same and thus the effect of total cholesterol 
level was independent from the patient’s age, consistent with 
a univariate effect.
After a Cox proportional hazard model based on the 
same set of variables was applied to the collected data, spe-
cific risk values were determined for the Polish population. 
Goodness of fit of both models, i.e. SCORE and Cox, to the 
observed CVD deaths was evaluated based on mortality rates 
in risk quartiles. 
Due to the fact that mortality risk was estimated using 
the maximum likelihood ratio method, the best (model) fit of 
the observed mortality rates was obtained in the Cox model 
risk quartiles. The difference between mortality rates in risk 
quartiles by the SCORE risk algorithm and the Cox model 
describes risk over- or underestimation in a specific SCORE 
risk quartile compared to the Cox model risk quartile. In both 
Tables presented, mortality rates in SCORE risk quartiles were 
overestimated compared to Cox model risk quartiles. The sum 
of absolute differences between these CVD mortality rates in 
all quartiles is the measure of disagreement of the SCORE risk 
algorithm in the Polish population versus the risk estimated 
using a Cox model. Overall disagreement was 5.7% in men 
and 2% in women. We believe these values are not high, if 
compared to previous Warsaw Pol-MONICA studies [15]. 
CONCLUSIONS
1. Long-term follow-up of WOBASZ and WOBASZ Senior 
study participants allowed assessment of the independent 
association of the evaluated cardiovascular risk factors 
with CVD mortality in the Polish population. 
2. Validation of the SCORE risk algorithm to estimate indi-
vidual global CVD risk in the Polish population showed 
a high predictive value of this algorithm.
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Ryzyko globalne zgonu z powodu chorób  
sercowo-naczyniowych dorosłej populacji  
polskiej: ocena prospektywna kohort  
zbadanych w wieloośrodkowych ogólnopolskich 
badaniach stanu zdrowia ludności  
— WOBASZ i WOBASZ Senior
Walerian Piotrowski, Anna Waśkiewicz, Alicja Cicha-Mikołajczyk
Instytut Kardiologii, Warszawa
S t r e s z c z e n i e
Wstęp i cel: Celem pracy było znalezienie dla populacji polskiej modelu ryzyka globalnego zgonu sercowo-naczyniowego 
i zweryfikowanie uzyskanych danych w kontekście ryzyka ocenianego wg algorytmu SCORE.
Metody: Materiał empiryczny stanowiły dane uzyskane z Wieloośrodkowych Ogólnopolskich Badań Stanu Zdrowia 
— WOBASZ i WOBASZ Senior. W latach 2003–2005 zbadano 14769 osób w wieku 20–74 lat w ramach badania WOBASZ, 
a w 2007 r. zbadano 1096 osób w wieku powyżej 74 lat w ramach badania WOBASZ Senior. Do 2012 r. zbierano informacje 
na temat wszystkich tych osób dotyczące wystąpienia zgonu oraz określono przyczynę zgonu. Średni okres obserwacji dla 
pacjentów z badania WOBASZ wynosił 8,2 roku, a dla pacjentów z badania WOBASZ Senior — około 5 lat. Ogółem zmarło 
1436 osób, zgonów kardiologicznych było 568. Do analiz statystycznych umieralności ogółem i spowodowanej chorobami 
układu sercowo-naczyniowego (CVD) wybrano 15 uznawanych czynników ryzyka. Analizę przeżywalności wykonano oddzielnie 
dla respondentów badań WOBASZ i WOBASZ Senior. Zastosowano metody statystyki opisowej, krzywe Kaplana-Meiera, model 
hazardów proporcjonalnych Coxa i algorytmu ryzyka incydentu sercowo-naczyniowego SCORE. Miarę niezgodności modelu 
SCORE do polskiej populacji określono jako różnicę między częstościami zgonów w kwartylach ryzyka wg skal SCORE i Coxa.
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Wyniki: W okresie 8 lat umieralność z powodu CVD stanowiła w „młodszej” (WOBASZ) populacji 38% wśród mężczyzn 
i 31% wśród kobiet ogółu zmarłych. Najczęstszymi przyczynami zgonu kardiologicznego u mężczyzn były: choroba niedo-
krwienna serca (33%) i choroby naczyń mózgu (17%), a u kobiet — choroby naczyń mózgu (31%) i choroba niedokrwienna 
serca (23%). Stwierdzono istotne statystycznie zróżnicowanie krzywych przeżycia między mężczyznami i kobietami zarówno 
dotyczących umieralności ogólnej (p < 0,0001), jak i umieralności z powodu CVD (p < 0,0001). Dla umieralności ogółem 
wśród mężczyzn i kobiet prawie wszystkie wybrane czynniki okazały się istotne statystycznie w analizach jednoczynnikowych, 
z wyjątkiem stężenia cholesterolu o wysokiej gęstości (HDL) i wskaźnika aterogenności u mężczyzn oraz statusu palenia tytoniu 
u kobiet. Jako niezależne w analizie wieloczynnikowej dla mężczyzn okazały się: wiek, stężenie glukozy, wartość ciśnienia 
tętniczego skurczowego i status palenia tytoniu, natomiast u kobiet niezależnymi predykatorami były: wiek, status palenia 
tytoniu i cukrzyca. W okresie 5 lat umieralność z powodu CVD stanowiła w „starszej” (WOBASZ Senior) populacji 48% wśród 
mężczyzn i 58% wśród kobiet ogółu zmarłych. Najczęstszymi przyczynami zgonu kardiologicznego zarówno u mężczyzn, jak 
i u kobiet była choroba niedokrwienna serca, odpowiednio 29% i 24%, a następnie choroby naczyń mózgu, odpowiednio 
16% i 21%. Wśród starszych pacjentów stwierdzono istotne statystycznie zróżnicowanie krzywych przeżycia dla umieralności 
ogółem między mężczyznami i kobietami (p < 0,0001), natomiast nie zanotowano statystycznego zróżnicowania umieralności 
spowodowanej CVD (p = 0,0755). W związku z faktem braku zróżnicowania krzywych przeżycia dla mężczyzn i kobiet dla 
umieralności z powodu CVD, wykonano estymację punktu odcięcia dla wieku w badaniu WOBASZ, przy którym rozpoczyna 
się brak zróżnicowania przeżywalności; wynosi on 70 lat. Począwszy od tego wieku przeżywalność z powodu CVD mężczyzn 
i kobiet nie różnią się istotnie. Dla umieralności ogółem wśród mężczyzn istotnymi statystycznie w analizach jednoczynniko-
wych okazały się: wiek i stężenie kreatyniny. Czynniki te pozostały istotne także w analizie wieloczynnikowej. Wśród kobiet 
w wieku powyżej 74 lat istotnymi czynnikami okazały się, pojedynczo, wiek, stężenie cholesterolu HDL, kreatyniny, wskaźnik 
aterogenności i palenie tytoniu. W modelu wieloczynnikowym natomiast niezależnymi predykatorami umieralności ogólnej 
pozostały: wiek, stężenie cholesterolu HDL, kreatyniny i palenie tytoniu. Dla umieralności spowodowanej CVD istotnymi 
czynnikami ryzyka okazały się te same zmienne co w przypadku umieralności ogółem. Wśród kobiet w analizach jednoczyn-
nikowych i w analizie wieloczynnikowej istotnymi predykatorami były wiek i palenie tytoniu. Uzyskano 5,7% niezgodności 
częstości zgonów między ryzykiem SCORE i ryzykiem Coxa u mężczyzn i 2% u kobiet.
Wnioski: 1. Wdrożenie programu obserwacji odległej osób zbadanych w programach WOBASZ i WOBASZ Senior, które 
były badaniami o zasięgu ogólnopolskim, stworzyło możliwość prześledzenia niezależnego związku analizowanych czynników 
ryzyka sercowo-naczyniowego z wystąpieniem zgonu z powodu CVD w populacji polskiej. 2. Weryfikacja algorytmu SCORE 
do oceny indywidualnego globalnego ryzyka CVD w populacji polskiej pokazała dużą wartość predykcyjną tego narzędzia.
Słowa kluczowe: WOBASZ, WOBASZ Senior, choroby układu sercowo-naczyniowego, ryzyko globalne, SCORE
Kardiol Pol 2016; 74, 3: 262–273
